Abstract

BackgroundIn immuno-oncology, accurate and actionable assessment of cellular mechanisms and interactions is paramount. The clinically validated multiplex immunofluorescence (mIF) assays at CellCarta accompanied by digital assays powered by RevealAI’s interactive...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call